Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cyxone chooses to complete acquisition of rabeximod

June 5, 2018

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

FDA approves Olumiant 2 mg for moderate to severe rheumatoid arthritis

June 4, 2018

Astellas submits application for marketing approval of peficitinib in Japan

June 1, 2018

Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint

May 31, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

Croma-Pharma identifies H2S-releasing compounds

May 28, 2018

Lupin submits MAA to the EMA for etanercept biosimilar

May 28, 2018

First patient enrolled in SARA-INT study of Sarconeos in sarcopenia

May 28, 2018

Chugai seeks Japanese approval for Actemra for adult-onset Still's disease

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...